sumifilam

Cassava Sciences Announces Positive Results In Phase 2 Trial Of New Alzheimer’s Drug
Forbes
Mon, 09/14/20 - 10:25 am
Cassava Sciences
clinical trials
Alzheimer's disease
sumifilam